Todd Sone is a General Partner at aMoon, where he brings over 20 years of healthcare investment experience as a sell side analyst, LP, and buy side investor to co-lead our Growth team. As a student, Todd worked part-time in his father’s pharmaceutical warehouse, which inspired him to pursue a career in the healthcare industry. His greatest passion is working with entrepreneurs to bring transformative products to market.
Todd sits on the boards of Biolojic Design, MOBILion, Scipher Medicine, Theranica, and Ultima Genomics. Before joining aMoon, Todd was a Managing Director at Signet Healthcare Partners, an investment fund that provides growth capital to commercial-stage life-science companies. He co-led the investment in Claris Lifesciences (sold to Baxter), and served on the boards of Arbor Pharmaceuticals (sold to KKR), Apicore (sold to Medicure), and Smart Medical Systems.
Prior to Signet, Todd served as an Investment Director at Joddes, a family office with interests in numerous lifescience companies, including Pharmascience, Medicom and Paladin Labs. Earlier in his career, Todd was an equity analyst at Morgan Stanley and Goldman Sachs in New York, covering the US pharmaceutical sector. He started his career as a strategy consultant with Mercer Management Consulting.
Todd received a Bachelor of Commerce with High Distinction from the University of Toronto, and an MBA from The Wharton School at the University of Pennsylvania with concentrations in healthcare management and finance.